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H. pylorimay be beneﬁcial to the patients with impaired glucose tolerance in addition to diet control.
© 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Helicobacter pylori
High-fat diet
Insulin resistance
Gut microbiota1. Introduction
It has been established that Helicobacter pylori infection can lead to
the development of many gastroduodenal diseases (Goh et al., 2011).
Accumulated evidence has suggested that this infection is associated
with metabolic diseases, such as metabolic syndrome (Chen et al.,
2015a; Chen et al., 2015b), type 2 diabetes mellitus (T2DM) (He et al.,
2014b) and atherosclerotic diseases (He et al., 2014a), yet the underly-
ing mechanism is obscure. Insulin resistance (IR) and subsequent
hyperinsulinemia are the key pathogenic factors contributing to these
metabolic abnormalities. Thus, investigating the impact of H. pylori in-
fection on insulin sensitivity may elucidate the association between
H. pylori and the metabolic diseases.
Increasing evidence has shown that the gutmicrobiota play a funda-
mental role in the pathogenesis of metabolic disorders like obesity and
T2DM, possibly through modulating energy balance, glucose metabo-
lism and chronic inﬂammatory response (Cani et al., 2008; Ley et al.,
2006; Musso et al., 2010). Thus far, the interaction of gastric microbiota
with H. pylori in human and animal models has been investigated, and
several of these microbes are supposed to contribute to H. pylori-
associated diseases such as gastric cancer (He et al., 2016). However,hip.
an open access article under thestudies regarding the impact of H. pylori infection on gut microbiota
are limited. In this study, we investigated the effect of H. pylori infection
on high-fat diet (HFD) induced IR and the associated alterations of gut
microbiota in C57BL/6 mice. We also assessed the levels of metabolic
hormones and cytokines in response to H. pylori colonization with or
without a HFD.
2. Material and Methods
2.1. Animals and H. pylori Strains
Six- to eight-week-old male C57BL/6 mice (Hunan Slac Jingda Labo-
ratory Animal Company, Ltd., Changsha, China) and two mouse-
adapted H. pylori strains including the Sydney strain (SS1) and
NCTC11637 were used in this study. TheH. pylori strains were inoculat-
ed on Campylobacter agar plates containing 10% sheep blood and incu-
bated at 37 °C under microaerophilic conditions (5% O2, 10% CO2, and
85%N2) for 24-48h and then subcultured in Brucella broth supplement-
ed with 10% FBS at 37 °C under the microaerophilic conditions for 16-
18 h. Bacterial density was estimated spectrophotometrically at
600 nm (OD600), and viable cells were determined as colony-forming
units (CFU)/ml (1 OD600= 109 CFU/ml). Animals were housed in a con-
trolled environment (12 h daylight cycle) with food and water ad
libitum. After 2 weeks of acclimation on a normal chow diet (Beijing
KeAoXieLi Company, Ltd., Beijing, China), the mice were randomlyCC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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gavage in a dosage of 1 × 109 CFU of H. pylori SS1 or NCTC11637 ﬁve
times at 2 day intervals, and concurrently fed either a chow diet or
HFD containing 45.37% lipids, 18.21% proteins and 36.42% carbohy-
drates, whereas the other two groups received the sterile Brucella
broth and were fed the corresponding diet. Body weight, food intake
and waist circumference were assessed twice a month. The waist cir-
cumference was measured at the midpoint between the lower ribs
and iliac crest with a measuring tape by two investigators who were
blinded as to which group the animal has been assigned (Knigge et al.,
2015; Zhang et al., 2007). All procedures were approved by the Ethics
Committee of The First Afﬁliated Hospital of Nanchang University.
2.2. Glucose Homeostasis
After 12 and 24weeks on different diets, micewere fasted overnight
(12 h) and the glucose tolerance test (IPGTT) was performed after the
mice were intraperitoneally injected with glucose (2 g/kg). Blood glu-
cose concentrations were measured using a handheld glucometer
(OneTouch Ultra Easy, LifeScan) via tail bleed before (0 min) and after
(15, 30, 60, 120min) the glucose injection. For the intraperitoneal insu-
lin tolerance test (IPITT), micewere fasted for 6 h and the glucose levels
were measured before (0 min) and after (15, 30, 60, 120 min) insulin
(0.75 U/kg) administration.
2.3. Blood Serum Analysis
At week 12 and 24, mice were fasted overnight and sacriﬁced for
subsequent analysis. Blood was collected into microfuge tubes and
allowed to clot for 30 min. Then samples were centrifuged at
3000 rpm for 20 min and serum was collected and stored at −80 °C
until analysis. Serum insulin (CrystalChem Inc.) was quantiﬁed by
ELISA. The homeostasis model assessment of insulin resistance
(HOMA-IR) index was calculated based on the following formula:
fasting insulinemia (μUI/ml) × fasting glycaemia (mM)/22.5. The con-
centrations of inﬂammatory cytokines IL-1β, IL-6 and TNF-α were
quantiﬁed using the Mouse Cytokine/Chemokine Magnetic Bead Panel
(Millipore). The Milliplex MAP Kit for Mouse Metabolic Magnetic Bead
Panel (Millipore)was used to quantify hormones including resistin, gas-
tric inhibitory polypeptide (GIP) and leptin.
2.4. 16S rRNA Gene Sequencing and Analysis
Fresh faeces were collected at different time points and total geno-
mic DNA from each sample was extracted using the QIAamp DNA
Stool Mini Kit (QIAGEN) according to the manufacturer's instructions.
DNA concentrations and integrity were assessed using a ﬂuorometer
and agarose gel electrophoresis. Then, the qualiﬁed DNA samples were
stored at−80 °C prior to 16S ribosomal RNA (rRNA) gene amplicon se-
quencing. The 16S rRNA gene amplicon sequencing was performed on
the Illumina MiSeq platform (BGI Tech Solutions Co., Ltd., Shenzhen,
China) according to protocols described by Caporaso et al. (2012)).
The sequences of the primers targeting the V4 hyper-variable region
of the bacterial 16S rRNA genes were as follows: 515F GTGCCAGC
MGCCGCGGTAA; 806R GGACTACHVGGGTWTCTAAT. The raw data
were ﬁltered to obtain clean reads by eliminating the adapter pollution
and low quality sequences (Fadrosh et al., 2014). High quality paired-
end reads were combined to tags with an average read length of
252 bp using FLASH (Fast Length Adjustment of Short reads, v 1.2.11)
(Magoc and Salzberg, 2011). The tags were then clustered as OTU (Op-
erational Taxonomic Unit) by scripts of USEARCH (v 7.0.1090) software
with a 97% similarity threshold (Edgar, 2013). The representative OTU
sequenceswere taxonomically classiﬁed using Ribosomal Database Pro-
ject (RDP) Classiﬁer v.2.2 trained on the Greengenes database. Finally,
an OTU table and a phylogenetic tree were generated for diversity anal-
ysis. Principal coordinate analysis (PCoA) was conducted according tothe distance matrices created by QIIME (v 1.80) (Caporaso et al.,
2010). Linear discrimination analysis coupled with effect size (LEfSe)
was performed to identify the bacterial taxa differentially represented
between groups at the genus or higher taxonomy levels (Segata et al.,
2011).
2.5. Western Blotting
10 mg of liver and jejunum tissue were homogenized using the
Mixer Mill MM 400 (Retsch) in lysis buffer (50 mM Tris-HCl, pH 7.8,
50 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM Na3VO4, 50 mM β-
glycerol-phosphate, 1 mMDTT, 0.5% TritonX-100, 10 mM NaF and pro-
tease inhibitors). Protein concentrations were determined using a
Coomassie brilliant blue staining method. An equal amount of protein
(20-25 μg) was separated on 10% SDS-PAGE gels and transferred to ni-
trocellulose membranes (Whatman GmbH, Dassel, Germany). After
the membranes were blocked with 5% nonfat milk in Tris-buffered sa-
line (TBS) containing 0.1% Tween-20 (TBST) at room temperature for
1 h, they were incubated overnight with the primary antibody at 4 °C.
Subsequently, the membranes were washed and incubated with HRP-
conjugated secondary antibody. Immuno-reactive proteins were de-
tected using an ECL kit (Bio-Rad, USA). Antibodies against protein ki-
nase B (Akt) and p-Akt (Ser473) were purchased from Cell Signaling
Technology, insulin receptor substrate 1 (IRS1) and p-IRS1 (Tyr896)
and occludin from Abcam, ZO-1 from Invitrogen and claudin-1 from
Life Technologies.
2.6. Statistical Analysis
Statistical analysis was performed using the SPSS 13.0 software. Data
are expressed as the means ± standard error of means (SEM). Groups
were compared by one-way ANOVA and LSD's multiple range test
with a value of p b 0.05 as the cut-off for statistical signiﬁcance.
3. Results
3.1. H. pylori Infection Accelerates Diet-induced Central Obesity
The C57BL/6 mice were successfully infected with H. pylori after 12
and 24 weeks, which was conﬁrmed by Giemsa staining while none of
the mice administered Brucella broth alone was positive for H. pylori
(Supplement Fig. 2). As shown in Fig. 1A and B, both the body weight
and the waist circumference were signiﬁcantly increased early after
HFD feeding. Interestingly, HFD-fed mice infected with H. pylori SS1
had a larger waist circumference without increased body weight com-
pared to that of the HFD controls. Moreover, the visceral fat, especially
the epididymal adiposemass,wasmuchheavier and the relative epidid-
ymal fat pad weight was signiﬁcantly greater in mice with H. pylori in-
fection after 12 weeks of HFD, the degree of which was almost
comparable to the level of 24weeks HFD controls (Fig. 1C and D). Addi-
tionally, in contrast to the HFD control group, H. pylori-infected mice
feeding HFD showed no difference of energy intake in comparison
with the controls but exhibited a signiﬁcant increase in energy efﬁcien-
cy at 12weeks (Fig. 1E and F). Together, these data suggest thatH. pylori
infection accelerates HFD-induced fat redistribution and the emergence
of central obesitywhichmay be related to the enhanced energy harvest.
3.2. H. pylori Infection Aggravates Early Diet-induced IR
We next examined the impact of H. pylori infection on glucose ho-
meostasis and insulin sensitivity in mice feeding a normal diet or HFD
after 12 and 24 weeks. We found that H. pylori-infected HFD-fed mice
displayed more severe IR compared to HFD controls at 12 weeks as re-
vealed by intraperitoneal insulin tolerance tests (IPITTs) (Fig. 2A). Al-
though H. pylori infection did not signiﬁcantly inﬂuence HFD-induced
glucose intolerance (Fig. 2B), the higher fasting hyperinsulinemia and
Fig. 1. Effects ofH. pylori infection and different dietary regiments on body composition.Micewere fed either a chow or a high-fat diet (HFD) for 12weeks and 24weeks.H. pylori-infected
groups were intragastrically administered either SS1 strain or NCTC11637 strain with a 2 day interval for a total of ﬁve infusions. Chow and HFD fed control groups were gavaged with
vehicle (Brucella broth). (A) Body weight curves; (B) abdominal circumference; (C) epididymisadipose mass; (D) epididymisadipose mass index (ratio between epididymisadipose
mass and body weight); (E) energy intake; (F) energy efﬁciency (ratio between body weight gain and energy intake). The body weight was signiﬁcantly increased by four weeks after
HFD. n = 8–10. Data are expressed as the mean ± SEM. *p b 0.05, **p b 0.01.
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values further supported that H. pylori infection aggravated IR after
12 weeks of HFD consumption (Fig. 2C and E). Moreover, the fasting
blood glucose was higher in HFD mice infected with H. pylori SS1 than
uninfected HFD controls (Fig. 2D), suggesting that H. pylori infection
had a synergistic effect on the dysregulation of glucose homeostasis.
We then measured the expression of insulin signaling proteins in liver
and found a substantial reduction in the phosphorylation of IRS1
(Tyr896) and Akt (Ser473) in H. pylori-infected mice administered a
HFD (Fig. 2F), further conﬁrming the deleterious effects of H. pylori in-
fection combined with HFD on IR. However, after long-term HFD con-
sumption, the diet itself had a strong effect on glucose dysregulation
that seems greater than H. pylori infection, as that the insulin sensitivity
was lower and the fasting insulin and HOMA-IR were higher in HFD
groups than the chow diet (CD) controls at 24weeks, with no statistical
difference between H. pylori-infected and non-infected groups (Fig. 2A,
C and E). We also found that the IR of HFD controls increased strikingly
at 24weeks comparedwith 12weeks as revealed by IPITTs,whereas the
H. pylori-infected HFD groups only increased slightly, which supported
the crucial role of diet after long-term treatment (Fig. 2G).
3.3. H. pylori Infection Inﬂuences the Circulating Metabolic Hormones In-
stead of Inﬂammatory Cytokines
Chronic inﬂammation and alterations inmetabolic hormones are be-
lieved to be responsible for IR. In our study, the serum levels of TNF-α,
IL-1β and IL-6 trended to be higher in animals infected with H. pyloriSS1 on a normal diet at 12 weeks, while no difference was observed be-
tween H. pylori-infected and non-infected groups in HFD (Fig. 3A-C).
Similarly, after 24 weeks the levels of these cytokines in HFD-fed
H. pylori-infected groups were not different from the HFD controls ex-
cept IL-6 (Supplement Fig. 3A–C). H. pylori has been reported to inﬂu-
ence physiological regulation of metabolic hormones involved in food
intake, energy expenditure and body mass (Khosravi et al., 2015). We
found that the serum level of gastric inhibitory polypeptide (GIP) and
leptin were higher in animals infected with H. pyloriwhen given a nor-
mal diet at 12 weeks compared to the non-infected controls, and the
level of GIP was further increased in H. pylori-infected group fed HFD
compared with HFD controls (Fig. 3D and E). Moreover, H. pylori infec-
tion apparently elevated the circulating level of resistinwhichwas iden-
tiﬁed to play a signiﬁcant role in the onset of IR after 12 weeks HFD
(Fig. 3F). At 24 weeks the level of resistin increased rapidly in the HFD
controls compared with 12 weeks and no signiﬁcant difference in
resistinwas observed in HFD groups regardless ofH. pylori infection sta-
tus (Fig. 3G and H). These results suggest that H. pylori infection inﬂu-
ences the secretion of metabolic hormones which associates with the
aggravation of IR at an early stage of HFD feeding although the diet itself
has a much stronger effect after long-term administration of HFD.
3.4. The Alteration of GutMicrobiota is Correlatedwith H. pylori-associated
IR
Accumulating evidence suggests that dysbiosis of gut microbiota
plays a vital role in triggering obesity, IR and other metabolic disorders
Fig. 2.H. pylori infection promotes diet-induced IR andhyperinsulinaemia at the early stage. The intraperitoneal insulin and glucose tolerance testswere performed at different time points
during the treatment (A, B). Mice were fasted overnight for plasma insulin (C), blood glucose (D) determination and the HOMA-IR index was calculated (E). Immunoblots of
phosphorylated insulin receptor substrate 1 (p-IRS1) (Tyr896) and phosphorylated Akt (p-Akt) (Ser473) in the chow or HFD groups with or without H. pylori infection (F). Area under
the curve for insulin tolerance tests after 12 and 24 weeks of HFD consumption in H. pylori-infected and non-infected groups (G). Data are expressed as the mean ± SEM. ⁎p b 0.05,
**p b 0.01.
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an ongoing crosstalk between H. pylori and the gut microbiota which
is associated with the gut inﬂammation (Khosravi et al., 2015). Thus,
we investigated whether the aggravating effect of H. pylori on HFD-
induced IR is associated with perturbation of the gut microbiota. The
16S rRNA gene sequencing of fecal samples at 12 weeks revealed that
H. pylori-infectedmice feedingHFD had a distinctmicrobiota communi-
ty that clustered separately from both the HFD controls and the chow
diet groups (Fig. 4A). Compared to the HFD controls at the phylum
level, the H. pylori-infected group feeding HFD had a signiﬁcantly in-
creasedproportion of sequences assigned to Firmicutes and Proteobacteria,
whereas reads assigned to Bacteroidetes and Verrucomicrobia were rela-
tively reduced (Fig. 4B). To identify bacterial taxa that were signiﬁcantlydifferentiated betweenH. pylori-infected andnon-infected groups feeding
HFD, a metagenomic biomarker discovery approach (LEfSe) was
used. We found that Desulfovibrionaceae and Mucispirillum spp.
sequences were signiﬁcantly enriched in the HFD-fed H. pylori
infected group, as were sequences from the families Helicobacter,
Lachnospiraceae, and Ruminococcaceae, while Akkermansia spp.,
Prevotella spp., and Biﬁdobacterium spp. were more abundant in
HFD controls (Fig. 4C). Given that intestinal dysbiosis in HFD-
fed animals may affect gut permeability and subsequently lead
to systematic inﬂammation and IR(Tran et al., 2015), we next ex-
amined the expression of the tight junction components including
occludin, zonula occludens-1 (ZO-1) and claudin-1 in the intestine. Ex-
pression of these proteins was signiﬁcantly reduced in H. pylori-infected
Fig. 3. Effects of H. pylori infection with different diets on circulating inﬂammatory cytokines and metabolic hormones. Serum levels of TNF-α (A), IL-1β (B) and IL-6 (C) were not
signiﬁcantly different between H. pylori-infected and non-infected mice regardless of the diet structure at 12 weeks. Animals with H. pylori infection, especially those fed a HFD,
showed signiﬁcant increases in serum levels of metabolic hormones including GIP (D), leptin (E) and resistin (F) compared to their vehicle-treated controls at 12 weeks. The level of
resistin increased rapidly in the HFD control group after 24 weeks compared with 12 weeks (G) and thus come up with H. pylori-infected groups fed HFD at 24 weeks (H). Data are
expressed as the mean ± SEM. *p b 0.05, **p b 0.01.
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However, at 24 weeks the principal coordinate analysis (PCoA) scores
clearly separated the HFD groups from the normal diet groups regardless
of H. pylori infection status, indicating the dominant role of HFD in mod-
ulating gut microbiota after long-term treatment (Fig. 4E and F).Consistent with the alterations in the gut microbiota, the insulin sensitiv-
ity was comparable between H. pylori-infected mice and non-infected
HFD-fed mice at 24 weeks but was signiﬁcantly different from the chow
diet groups. These results suggest that H. pylori-associated IR after early
HFD is closely correlatedwith the speciﬁcmodiﬁcations of gutmicrobiota.
Fig. 4. The interaction ofH. pylori infection andHFD induces the alteration of gutmicrobiotawhich is associatedwith IR.Microbiota compositionwas analyzed in faeces ofH. pylori-infected
and non-infected mice fed either chow or HFD (n = 5 for each group). (A) Plots shown were generated using the weighted version of the UniFrac-based Principal coordinate analysis
(PCoA) after 12 weeks. Samples from H. pylori-infected mice fed HFD included in the red circle clustered distinctly from those of HFD-fed controls embraced in the blue circle.
(B) Bacterial taxonomic proﬁling at the phylum level of gut bacteria from different groups after 12 weeks. (C) Linear discriminant analysis (LDA) coupled with effect size
measurements identiﬁes the most differentially abundant taxa between HFD-fed mice with H. pylori infection and HFD controls after 12 weeks. HFD controls-enriched taxa are
indicated with a negative LDA score (red), and taxa enriched in H. pylori-infected HFD group have a positive score (green). Only taxa meeting an LDA signiﬁcant threshold of N2 are
shown. (D) The jejunum tissues of mice were analyzed for the expression of intestinal tight junction proteins including ZO-1, occludin and claudin-1 after 12 weeks. The PCoA (E) and
unweighted pair group method with arithmetic mean (UPGMA) (F) analysis showed the alterations of microbial community after 24 weeks. Samples from the HFD group regardless of
H. pylori infection status clustered together in the red circle which are different from those given chow diet in the blue circle.
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After the ﬁrst prospective cohort study demonstrated that H. pylori
infection resulted in an increased rate of incident diabetes, following
studies also showed that H. pylori infection was signiﬁcantly associated
with higher levels of HbA1c which is a valid and reliable biomarker for
long-term blood glucose level in humans (Chen and Blaser, 2012;
Hsieh et al., 2013; Jeon et al., 2012). Moreover, a recent randomized
double-blind placebo-controlled trial demonstrated that H. pylori erad-
ication improves glucose homeostasis in patients with type 2 diabetes
by decreasing HOMA-IR and fasting insulin levels (Bonﬁgli et al.,
2016). In a previous study, we also found in Mongolian gerbils that
long-term H. pylori infection induced increased levels of HbA1c, but its
effect on glucose tolerance and the underlyingmechanism remains un-
clear (Yang et al., 2015). Despite the positive association between
H. pylori and insulin resistance reported in some researches, there
are opposite perspectives denying their relationship (Upala and
Sanguankeo, 2016). Thus more investigation is needed to determine
whether there are some other factors involving in the association be-
tween H. pylori and insulin resistance which could account for the
discrepancies.
Given the increasing intake of high-fat and high-calorie diets in the
post-industrialization era and the high prevalence of H. pylori infection
at a global level, we therefore investigated the impact of H. pylori infec-
tion in combination with HFD on body insulin sensitivity and subse-
quent predisposition to metabolic disorders. Our ﬁndings of increased
visceral fat and larger waist circumference in H. pylori-infected mice
after 12 weeks HFD, which almost reached the level of 24 weeks of
HFD, suggest thatH. pylori infectionmay accelerate HFD-induced fat re-
distribution and the emergence of central obesity. We also demonstrat-
ed that H. pylori infection aggravated HFD-induced IR, and this effect
occurred at the early stage. These results are consistent with previous
observation in humans indicating that the role of H. pylori in impaired
glucose tolerance may be potentiated by higher body mass index level
(Chen and Blaser, 2012). In the present study, we showed that the ex-
pressions of p-IRS1 (Tyr896) and the downstream protein p-Akt
(Ser473) in the liver of mice with H. pylori infection were decreased
after early HFD administration. The changes in phosphorylation of insu-
lin signaling proteins could directly lead to IR(Xu et al., 2014). After
24 weeks of HFD, we found that the IR of the control group was much
higher than that of 12 weeks and almost come up with the H. pylori-
infected groups. These results suggest that diet itself exerts a strong ef-
fect on glucose dysregulation that seems greater than H. pylori infection
after long-term HFD.
Recently, the gut microbiota has emerged as an essential modulator
that inﬂuences host metabolism and has been suggested to play a vital
role in metabolic diseases. H. pylori, an ancient gastric pathogen, has
been reported to interact with other gastric microbiota whereas the lit-
erature regarding its association with gut microbiota is rare (He et al.,
2016). Our study demonstrated that there is an interaction of H. pylori,
diet and gut microbiota, and the adverse effect of H. pylori on IR is asso-
ciated with gut microbiota. Using 16S rRNA gene sequence analysis, we
showed that H. pylori induced a dramatic shift in the gut microbiota of
mice feeding HFD by increasing the proportion of Firmicutes and de-
creasing the proportion of Bacteroidetes. This phylum-wide pattern of
compositional reshape in the microbial community has been thought
to be a typical characteristic of obesity-driven dysbiosis as shown in
both overweight humans and animals (Cotillard et al., 2013; Mozes
et al., 2008). Additionally, H. pylori infection with HFD induced a de-
creased percentage of Verrucomicrobia, which was mostly contributed
by a signiﬁcant reduction of Akkermansia spp. Akkermansiawithin the
mucus layer has been implicated in regulating the gut barrier function
and protecting the host from obesity-linked metabolic syndrome
(Everard et al., 2013; Roopchand et al., 2015). Oral administration
of this bacterium (i.e., as a probiotic) has been reported to reverse
HFD-induced metabolic disorders and also mimic the antidiabeticeffects of metformin in diabetic mice (Everard et al., 2013; Shin et al.,
2014). In contrast, several bacterial families like Desulfovibrionaceae,
Ruminococcaceae and Lachnospiraceae were enriched, which is consis-
tent with prior reports that similar alterations of themicrobial commu-
nities are positively correlated with the development of metabolic
diseases (Kameyama and Itoh, 2014; Kim et al., 2012; Zhang et al.,
2010). Identiﬁed as the potentially important endotoxin producers,
members in Desulfovibrionaceae are capable of reducing sulphate to
H2S and damaging the gut barrier (Zhang et al., 2010). Our results
showed that H. pylori infection in combination with HFD decreased
the expression of tight junction proteins in the intestine, and the impair-
ment of intestinal integritymay in turn facilitate the release of endotox-
in into the bloodstream and therefore promotemetabolic inﬂammation
and IR (Cani et al., 2008). After 24 weeks, the microbiota community
from HFD-fed mice with H. pylori infection clustered together with the
HFD controls, both of which were separated from the normal diet
groups. Thus, we speculate that there is a close correlation between
gutmicrobiota andmetabolic phenotype and changes in several keymi-
crobiota populations afterH. pylori infection play a critical role in the ag-
gravation of IR.
Although the serum levels of some inﬂammatory cytokines such as
TNF-α were not elevated in H. pylori-infected HFD mice, the increased
abundance of Desulfovibrionaceae which can produce endotoxins and
the compromised intestinal barrier cast some doubt on the role of in-
ﬂammation. In addition to inﬂammation hypothesis, increasing evi-
dence indicates that H. pylori infection can inﬂuence the production of
metabolic hormones involved in energy homeostasis both in human
and animal studies, which is another potential mechanism for
H. pylori-associated insulin resistance (Boltin and Niv, 2012; Khosravi
et al., 2015; Roper et al., 2008). In our study, we also found remarkable
changes of metabolic hormones afterH. pylori infection given HFD. Both
GIP and resistin which have been reported to play a cardinal role in IR
and associatedmetabolic disturbanceswere observed to increase signif-
icantly inH. pylori-infectedmicewithHFD at the early stage (Gault et al.,
2005; Muse et al., 2004). Moreover, the HFD itself induced dramatic el-
evation of circulating resistin after long-term treatment, and thus no
statistical difference was observed between H. pylori-infected and
non-infected groups. The changes of resistin are consistent with the al-
teration in body IR, which indicates the role of metabolic hormones in
H. pylori-associated IR.
Both H. pylori strains used in this study are observed to promote
HFD-induced metabolic disorders, although the degree of their patho-
genicity is not identical. The discrepancies in the association of
H. pylori and IR in epidemiological studies are likely due to the infection
of different strains as well as diet consumption. Further experiments
using germ-free animals are highlywarranted to elucidate the causal re-
lationship between gut microbiota and H. pylori-associated IR in the
presence of HFD.
In conclusion, we found that H. pylori infection promoted HFD-
induced central obesity and IR at the early stage, the extent of which
is close to the effect of long-term HFD. Meanwhile, we observed a dy-
namic alteration in the gutmicrobiota that is consistentwith the chang-
es of metabolic phenotype (Supplement Fig. 4). Thus, there may be an
interaction amongH. pylori, diet and gutmicrobiota,which dysregulates
host metabolic homeostasis and the treatment of H. pylorimay be ben-
eﬁcial to the patientswith impaired glucose tolerance in addition to diet
control.
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